Identification of two novel mutations inOCTN2of three patients with systemic carnitine deficiency
β Scribed by F.M. Vaz; H.R. Scholte; J. Ruiter; L.M. Hussaarts-Odijk; R. Rodrigues Pereira; S. Schweitzer; J.B.C. de Klerk; H.R. Waterham; R.J.A. Wanders
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 68 KB
- Volume
- 105
- Category
- Article
- ISSN
- 0340-6717
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Primary systemic carnitine deficiency (SCD) is an autosomal recessive disorder of fatty acid oxidation caused by defective cellular carnitine transport. The disease is characterized by metabolic derangement simulating ReyeΒ΄s syndrome, hypoglcaemia, progressive cardiomyopathy and skeletal myopathy. R
## Carnitine palmitoyltransferase II (CPT II) deficiency manifests as two different clinical phenotypes: a muscular form and a hepatic form. We have investigated three nonconsanguineous Japanese patients with CPT II deficiency. Molecular analysis revealed two missense mutations, a glutamate (174)to
## Abstract Steroid 21βhydroxylase deficiency is present in more than 90% of patients with congenital adrenal hyperplasia (CAH), an inherited metabolic disorder of adrenal steroidogenesis. Impaired enzymatic activity leads to the accumulation of metabolic intermediates (progesterone and 17βhydroxyp